These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38091076)

  • 1. Study on the mechanism of vitamin E alleviating non-alcoholic fatty liver function based on non-targeted metabolomics analysis in rats.
    Zhao B; Zhang J; Zhao K; Zhao W; Shi Y; Liu J; Zeng L; Wang C; Zeng X; Shi J
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4299-4307. PubMed ID: 38091076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerobic exercise and vitamin E improve high-fat diet-induced NAFLD in rats by regulating the AMPK pathway and oxidative stress.
    Bai Y; Li T; Liu J; Wang Y; Wang C; Ju S; Zhou C; Chen Y; Yao W; Xiong B
    Eur J Nutr; 2023 Sep; 62(6):2621-2632. PubMed ID: 37219594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shenling Baizhu powder alleviates non-alcoholic fatty liver disease by modulating autophagy and energy metabolism in high-fat diet-induced rats.
    Pan M; Deng Y; Qiu Y; Pi D; Zheng C; Liang Z; Zhen J; Fan W; Song Q; Pan J; Li Y; Yan H; Yang Q; Zhang Y
    Phytomedicine; 2024 Jul; 130():155712. PubMed ID: 38763008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways.
    You L; Wang T; Li W; Zhang J; Zheng C; Zheng Y; Li S; Shang Z; Lin J; Wang F; Qian Y; Zhou Z; Kong X; Gao Y; Sun X
    J Ethnopharmacol; 2024 Jul; 329():118165. PubMed ID: 38588984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Regulatory Mechanism of Smilax China L. Saponins against Nonalcoholic Fatty Liver Is Revealed by Metabolomics and Transcriptomics.
    Li C; Fang B; Wei Y; Mo R; Lin X; Huang Q
    J Oleo Sci; 2024; 73(5):695-708. PubMed ID: 38692892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated network pharmacology, metabolomics, and transcriptomics of Huanglian-Hongqu herb pair in non-alcoholic fatty liver disease.
    Zhang X; Zhang J; Zhou Z; Xiong P; Cheng L; Ma J; Wen Y; Shen T; He X; Wang L; Zhang Y; Xiao C
    J Ethnopharmacol; 2024 May; 325():117828. PubMed ID: 38325669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum.
    Yang XX; Wang X; Shi TT; Dong JC; Li FJ; Zeng LX; Yang M; Gu W; Li JP; Yu J
    Biomed Pharmacother; 2019 Sep; 117():109083. PubMed ID: 31387169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics Characterizes the Effects and Mechanisms of Quercetin in Nonalcoholic Fatty Liver Disease Development.
    Xu Y; Han J; Dong J; Fan X; Cai Y; Li J; Wang T; Zhou J; Shang J
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Untargeted metabonomics reveals intervention effects of chicory polysaccharide in a rat model of non-alcoholic fatty liver disease.
    Zhu H; Wang Z; Wu Y; Jiang H; Zhou F; Xie X; Wang R; Hua C
    Int J Biol Macromol; 2019 May; 128():363-375. PubMed ID: 30690116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective mechanisms of macroalgae Laminaria japonica consumption against lipid metabolism disorders in high-fat diet-induced hyperlipidemic rats.
    Zhang Q; Fan XY; Guo WL; Cao YJ; Lin YC; Cheng WJ; Chen LJ; Rao PF; Ni L; Lv XC
    Food Funct; 2020 Apr; 11(4):3256-3270. PubMed ID: 32219261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactive proteins and antioxidant peptides from Litsea cubeba fruit meal: Preparation, characterization and ameliorating function on high-fat diet-induced NAFLD through regulating lipid metabolism, oxidative stress and inflammatory response.
    Li L; Wang YM; Zeng XY; Hu Y; Zhang J; Wang B; Chen SX
    Int J Biol Macromol; 2024 Nov; 280(Pt 4):136186. PubMed ID: 39357720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.
    Jian T; Yu C; Ding X; Chen J; Li J; Zuo Y; Ren B; Lv H; Li W
    J Oleo Sci; 2019 Jun; 68(6):581-589. PubMed ID: 31092797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rapamycin on hepatic metabolomics of non-alcoholic fatty liver rats based on non-targeted platform.
    Zhao B; Zhang J; Zhao K; Wang B; Liu J; Wang C; Zeng L; Zeng X; Luo Y
    J Pharm Biomed Anal; 2025 Jan; 253():116541. PubMed ID: 39489928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active form of vitamin D ameliorates non-alcoholic fatty liver disease by alleviating oxidative stress in a high-fat diet rat model.
    Zhu CG; Liu YX; Wang H; Wang BP; Qu HQ; Wang BL; Zhu M
    Endocr J; 2017 Jul; 64(7):663-673. PubMed ID: 28539530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin E alleviates non-alcoholic fatty liver disease in phosphatidylethanolamine N-methyltransferase deficient mice.
    Presa N; Clugston RD; Lingrell S; Kelly SE; Merrill AH; Jana S; Kassiri Z; Gómez-Muñoz A; Vance DE; Jacobs RL; van der Veen JN
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):14-25. PubMed ID: 30300671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
    Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
    Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
    Dwivedi DK; Jena GB
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats.
    Ma Z; Chu L; Liu H; Wang W; Li J; Yao W; Yi J; Gao Y
    Sci Rep; 2017 Mar; 7():44819. PubMed ID: 28300221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of pharmacodynamics and metabolomics to reveal rhubarb anthraquinone protection against nonalcoholic fatty liver disease rat model.
    Zhang F; Wu R; Liu Y; Dai S; Gong X; Li Y
    J Pharm Pharmacol; 2024 Apr; 76(4):381-390. PubMed ID: 38349666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats.
    Yao X; Xia F; Tang W; Xiao C; Yang M; Zhou B
    J Ethnopharmacol; 2018 Feb; 212():208-215. PubMed ID: 29031784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.